Oculis Holding AG (OCS) Cash & Current Investments (2021 - 2026)

Oculis Holding AG (OCS) recorded quarterly Cash & Current Investments of $304.9 million in Q1 2026, up 14.42% quarter-over-quarter from $266.5 million in Q4 2025, and up 83.07% on a YoY basis from $166.6 million in Q1 2025.

Oculis Holding AG (OCS) Cash & Current Investments (2021 - 2026) Analysis & Trends

Oculis Holding AG's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $304.9 million for Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 83.07% year-over-year to $304.9 million; the TTM figure through Mar 2026 stood at $304.9 million (up 83.07% YoY), while the FY2025 annual figure was $266.5 million, up 136.64% from the prior year.
  • Cash & Current Investments was $304.9 million for Q1 2026 at Oculis Holding AG, up from $266.5 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $304.9 million in Q1 2026 to a low of $20.5 million in Q4 2022.
  • Historically, Cash & Current Investments has averaged $124.4 million across 5 years, with a median of $110.5 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Cash & Current Investments slumped 59.08% in 2022, then soared 402.89% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $20.5 million in 2022, then surged by 301.3% to $82.4 million in 2023, then soared by 36.65% to $112.6 million in 2024, then surged by 136.64% to $266.5 million in 2025, then grew by 14.42% to $304.9 million in 2026.
  • The last three Cash & Current Investments figures came in at $304.9 million (Q1 2026), $266.5 million (Q4 2025), and $158.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 32.30 Mn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 2.13 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 286.70 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 2.77 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 18.44 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 7.25 Bn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 304.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 304.95 Mn
Dec 31, 2025 266.52 Mn
Sep 30, 2025 158.07 Mn
Jun 30, 2025 193.62 Mn
Mar 31, 2025 166.57 Mn
Dec 31, 2024 112.63 Mn
Sep 30, 2024 124.85 Mn
Jun 30, 2024 124.29 Mn
Mar 31, 2024 107.58 Mn
Dec 31, 2023 82.42 Mn
Sep 30, 2023 108.30 Mn
Jun 30, 2023 102.17 Mn
Mar 31, 2023 21.39 Mn
Dec 31, 2022 20.54 Mn
Sep 30, 2022 47.92 Mn
Jun 30, 2022 48.05 Mn
Dec 31, 2021 50.19 Mn